ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity

Chemoresistance remains a major drawback to osteosarcoma treatment. ZBTB7A, a member of the POK transcription repressor family, was shown to play an important role in tumorigenesis. However, the effect of ZBTB7A on osteosarcoma chemoresistance is completely unknown. In this study, we found that ZBTB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lu, Wang, Yuan, Li, Xiaojie, Xia, Xin, Li, Na, He, Ruiping, He, Hongtao, Han, Chuanchun, Zhao, Wenzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609875/
https://www.ncbi.nlm.nih.gov/pubmed/28942243
http://dx.doi.org/10.1016/j.neo.2017.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609875/
https://www.ncbi.nlm.nih.gov/pubmed/28942243
http://dx.doi.org/10.1016/j.neo.2017.08.008

Ejemplares similares